Gene expression data demonstrated that clinical breast cancer tissues from patients with a bone or brain metastatic status had higher IL-22R1 and S1PR1 levels compared to non-mineral metastatic breast cancer cases (p < 0.05, Figure 1E). This evidence concerns the gene IL22RA1 and breast cancer.